Study of the efficacy of of using Eucerin pro acne solution SOS serum and Eucerin pro acne solution 3X treatment gel to foam cleanser in mild acne vulgaris.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240523002

Enrollment

Registered

2024-05-23

Start date

2024-06-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with mild acne vulgaris. acne vulgaris, acne treatment

Interventions

The skincare formulation combines Licochalcone A, AHA/BHA/PHA complex, Decanediol, L-carnitine

Experimental Other

Eucerin pro acne solution SOS serum

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy patients with mild severity grades of acne vulgaris

Exclusion criteria

Exclusion criteria: 1. Patients with concurrent facial skin infections 2. History of allergy to the study product components. 3.History of systemic acne treatment within the 4 weeks prior to the study 4. History of oral isotretinoin within the 6 months prior to the study 5.History of topical acne treatment within the 2 weeks prior to the study

Design outcomes

Primary

Measure	Time frame
Acne lesion counting baseline, 1 weeks, 4 weeks, 8 weeks Inflammatory and non-inflammatory acne counting number	—

Secondary

Measure	Time frame
Patients' assessment score baseline, 1 weeks, 4 weeks, 8 weeks grade 0, none; grade 1, mild; grade 2, moderate; grade 3, severe.,Investigator Global Assessment baseline, 1 weeks, 4 weeks, 8 weeks investigator global evaluation acne (IGEA),Patients' satisfaction score 8 weeks grade 0, minimum; grade 10, maximum.,Biophysical changes of skin (skin hydration, trans-epidermal water loss, pH, erythema) baseline, 1 weeks, 4 weeks, 8 weeks using Corneometer (unit from 0 (no water at all) - 120 (on water)), Tewameter (g/m2/h), pH meter(a scale of 0 to 14) and Antera3D (erythema index(unit))	—

Measure

Time frame

Patients' assessment score baseline, 1 weeks, 4 weeks, 8 weeks grade 0, none; grade 1, mild; grade 2, moderate; grade 3, severe.,Investigator Global Assessment baseline, 1 weeks, 4 weeks, 8 weeks investigator global evaluation acne (IGEA),Patients' satisfaction score 8 weeks grade 0, minimum; grade 10, maximum.,Biophysical changes of skin (skin hydration, trans-epidermal water loss, pH, erythema) baseline, 1 weeks, 4 weeks, 8 weeks using Corneometer (unit from 0 (no water at all) - 120 (on water)), Tewameter (g/m2/h), pH meter(a scale of 0 to 14) and Antera3D (erythema index(unit))

—

Countries

Thailand

Contacts

Public ContactPawinee Rerknimitr

Faculty of Medicine, Chulalongkorn University

Pawinee.R@chula.ac.th66816291862

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026